Project Description


Stardots have been working on The ANLIVA™ Platform, for biomarker and treatment optimisation of Parkinson’s disease.

ANLIVA™ is a digital health platform aiming to provide automatic, reliable indications of Parkinson’s disease treatment efficiency. They are creating Anliva to assist clinicians that need to make the most of precision treatments.

Their goal is to attain the best therapeutical effect in each patient as fast as possible, with the least risk of side effects. With self-tracking and robust symptom monitoring more accessible to both clinicians and patients, Anliva also supports the ongoing shift to patient-centered care.

Stardots joined NOME in 2023.

Company details


More companies